全球体外受精 (IVF) 显微镜市场:市场规模、占有率、成长分析、按产品类型、按最终用户划分 - 产业预测,2023-2030 年
市场调查报告书
商品编码
1396182

全球体外受精 (IVF) 显微镜市场:市场规模、占有率、成长分析、按产品类型、按最终用户划分 - 产业预测,2023-2030 年

Global In-vitro Fertilization Microscopes Market Size, Share, Growth Analysis, By Product Type(Inverted microscopes, stereo microscopes), By End-user(Fertility clinics, hospitals) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2021年,全球体外受精(IVF)显微镜市场规模为1.0405亿美元,从2022年的1.1611亿美元成长到2030年的1.1611亿美元,预测期间(2023-2030年)复合年增长率为7.43%。预计将成长至20603万美元。

全球体外受精 (IVF) 显微镜市场目前正在快速成长,预计在可预见的未来将保持这种上升趋势。促成这一市场扩张的主要因素包括全球不孕症发病率的增加、显微镜技术的不断进步以及人们对不孕症治疗成功率的认识不断提高。不孕率上升是由于生活方式的改变、环境影响以及推迟怀孕的趋势,导致对辅助生殖技术的需求增加,特别是体外受精(IVF),而IVF)正在推动显微镜市场的发展。此外,显微镜技术的不断进步彻底改变了辅助生殖技术领域。高解析度成像功能和创新功能的提供彻底改变了胚胎可视化和操作。因此,生育专家能够提高体外受精的成功率。人们对不孕症治疗有效性的认识不断提高,进一步推动了市场的成长,越来越多的患者和医疗保健提供者选择体外受精 (IVF) 显微镜。此外,政府的支持措施和医疗基础设施的发展也在市场扩张中发挥重要作用。新兴市场的一个趋势是开发专专用体外受精 (IVF) 设计的便携式手持式显微镜。这些紧凑的携带式设备提供了极大的弹性和便利性,有助于现场不孕症测试和诊断。携带式显微镜使生育专家能够进行现场评估,减少样本运输的需要,并在体外受精 (IVF) 过程中实现即时决策,这将成为可能。这一趋势在资源有限的环境中尤其有利,并将大大有助于提高不孕症治疗的可近性。

体外受精 (IVF) 显微镜全球市场区隔分析

全球体外受精 (IVF) 显微镜市场可根据产品类型、最终用户和地区进行细分。依产品类型分为倒置显微镜、体视显微镜、萤光显微镜和共聚焦显微镜。依最终用户划分,市场分为生育诊所、医院和研究机构。依地区划分,分为北美、欧洲、亚太地区、中东/非洲、拉丁美洲。

体外受精 (IVF) 显微镜的全球市场驱动因素

全球不孕症现像日益增加:由于生活方式改变、环境影响、延迟怀孕等导致不孕症患者数量迅速增加,是推动辅助生殖技术尤其是体外受精需求的主要因素。随着越来越多的个人和夫妇在自然受孕方面面临挑战,对先进辅助生殖技术(包括使用体外受精 (IVF) 显微镜)的需求显着增加。这种不断增长的需求正在为製造商和行业供应商创造有利的市场形势。

全球体外受精(IVF)显微镜市场的抑制因素

IVF治疗及相关技术高成本:IVF治疗涉及多个週期、药物治疗、实验室检查以及精密显微镜设备的使用,对患者来说不经济,是一个很大的负担。体外受精治疗的高成本可能会限制其可用性和普及,从而阻碍其广泛使用。此外,体外受精 (IVF) 显微镜及其维护的高成本可能会影响其普及,特别是在资源有限的环境和经济困难的患者中。

体外受精 (IVF) 显微镜的全球市场趋势

强调延时成像技术:延时成像技术在体外受精 (IVF) 中越来越受到关注,在胚胎发育过程中定期连续拍摄影像。该技术提供了胚胎品质和动态的宝贵见解,并允许对型态变化和发育里程碑进行详细评估。生育专家正在利用这一趋势来非侵入性地监测胚胎髮育,并旨在透过选择具有更高发育潜力的胚胎来提高体外受精的成功率。延时成像的采用反映了在体外受精 (IVF) 过程中改善胚胎选择和移植决策的策略重点。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
  • 主要市场考察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • Start-Ups分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 主要投资分析
    • 关键成功因素
    • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
    • 监管形势
    • 波特的分析
    • 对未来中断的特殊考察
  • 按产品类型分類的全球体外受精 (IVF) 显微镜市场
    • 市场概况
    • 倒置显微镜
    • 体视显微镜
    • 萤光显微镜
    • 共聚焦显微镜
  • 全球体外受精 (IVF) 显微镜市场:依最终用户分类
    • 市场概况
    • 不孕不育诊所
    • 医院
    • 研究机构
  • 按地区分類的体外受精 (IVF) 显微镜的全球市场规模
    • 市场概况
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 西班牙
      • 法国
      • 英国
      • 其他欧洲国家地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲 (MEA)
      • 海湾合作委员会国家
      • 南非
      • 其他中东/非洲地区
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场定位(2021年)
    • 主要市场参与者所采取的策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率(2021年)
  • 主要企业简介
    • Leica Microsystems GmbH(Germany)
    • Nikon Corporation(Japan)
    • Olympus Corporation(Japan)
    • Carl Zeiss AG(Germany)
    • Thermo Fisher Scientific Inc.(US)
    • CooperSurgical, Inc.(US)
    • Research Instruments Ltd.(UK)
    • Vitrolife AB(Sweden)
    • Eppendorf AG(Germany)
    • Hamilton Thorne, Inc.(Canada)
    • RI.MOS. srl(Italy)
    • Kitazato Corporation(Japan)
    • Esco Micro Pte. Ltd.(Singapore)
    • Labotect GmbH(Germany)
    • Microptic SL(Spain)
    • Cook Medical LLC(US)
    • Xilloc Medical BV(Netherlands)
    • K-Systems Corp.(US)
    • IVFtech ApS(Denmark)
    • Genea Biomedx(Australia)
简介目录
Product Code: SQMIG35A2620

Global In-Vitro Fertilization Microscopes Market size was valued at USD 104.05 million in 2021 and is poised to grow from USD 116.11 million in 2022 to USD 206.03 million by 2030, at a CAGR of 7.43% during the forecast period (2023-2030).

The global market for in-vitro fertilization microscopes is currently undergoing rapid growth and is anticipated to sustain this upward trajectory in the foreseeable future. This expansion is primarily driven by key factors, including the increasing prevalence of infertility worldwide, continuous advancements in microscopy technology, and a growing awareness of the favourable success rates associated with fertility treatments. The rise in infertility rates is attributable to lifestyle shifts, environmental influences, and the tendency to postpone pregnancies, consequently generating heightened demand for assisted reproductive technologies, specifically in-vitro fertilization, thereby propelling the market for IVF microscopes. Moreover, the ongoing evolution of microscopy technology has brought about a significant transformation in the field of assisted reproduction. The provision of high-resolution imaging capabilities and innovative features has revolutionized embryo visualization and manipulation. This, in turn, enables fertility specialists to achieve enhanced success rates in IVF procedures. The increasing awareness of the efficacy of fertility treatments has further catalysed market growth, with a growing number of patients and healthcare providers opting for IVF microscopes. Additionally, supportive government initiatives and improvements in healthcare infrastructure are playing a pivotal role in facilitating the expansion of the market. An emerging trend in the market is the development of portable and handheld microscopes specifically designed for in-vitro fertilization. These compact and mobile devices offer a high degree of flexibility and convenience, facilitating point-of-care fertility testing and diagnosis. The use of portable microscopes empowers fertility specialists to conduct on-site evaluations, thereby reducing the necessity for sample transportation and enabling real-time decision-making during the IVF process. This trend proves particularly advantageous in resource-limited settings and contributes significantly to enhancing accessibility to fertility treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Fertilization Microscopes Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global In-Vitro Fertilization Microscopes Market Segmental Analysis

The global In-vitro Fertilization Microscopes market can be segmented based on product type, end-user and region. Based on product type, the market can be segmented into inverted microscopes, stereo microscopes, fluorescence microscopes, confocal microscopes. Based on end-use, the market can be segmented into Fertility clinics, hospitals, research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global In-Vitro Fertilization Microscopes Market

Increasing Global Incidence of Infertility: The surge in infertility cases, attributed to lifestyle shifts, environmental influences, and delayed pregnancies, is a primary driver propelling the demand for assisted reproductive technologies, notably in-vitro fertilization. As a growing number of individuals and couples encounter challenges in natural conception, the demand for advanced fertility treatments, including the utilization of IVF microscopes, experiences a significant upswing. This escalating demand creates a favourable market landscape for manufacturers and industry suppliers.

Restraints in the Global In-Vitro Fertilization Microscopes Market

High Cost of IVF Treatments and Associated Technologies: The expense associated with IVF procedures, encompassing multiple cycles, medications, laboratory tests, and the use of advanced microscopy equipment, presents a considerable financial burden for patients. The elevated cost of IVF treatments may limit accessibility and affordability, hindering widespread adoption. Furthermore, the high cost of IVF microscopes and their maintenance may impact adoption rates, especially in resource-limited settings and among patients with constrained financial resources.

Market Trends of the Global In-Vitro Fertilization Microscopes Market

Emphasis on Time-Lapse Imaging Technology: Time-lapse imaging technology is gaining prominence within in-vitro fertilization, involving the continuous capture of images at regular intervals during embryo development. This technique enables a detailed assessment of morphological changes and developmental milestones, offering valuable insights into embryo quality and kinetics. Fertility specialists leverage this trend for non-invasive monitoring of embryo development, aiming to enhance IVF success rates by selecting embryos with the highest developmental potential. The adoption of time-lapse imaging reflects a strategic focus on improving decision-making in embryo selection and transfer during IVF procedures.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global In-vitro Fertilization Microscopes Market by Product Type
    • Market Overview
    • Inverted microscopes
    • stereo microscopes
    • fluorescence microscopes
    • confocal microscopes
  • Global In-vitro Fertilization Microscopes Market by End-user
    • Market Overview
    • Fertility clinics
    • hospitals
    • research institutes
  • Global In-vitro Fertilization Microscopes Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Leica Microsystems GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nikon Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Olympus Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carl Zeiss AG (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Thermo Fisher Scientific Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CooperSurgical, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Research Instruments Ltd. (UK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitrolife AB (Sweden)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Eppendorf AG (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Hamilton Thorne, Inc. (Canada)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • RI.MOS. srl (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Kitazato Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Esco Micro Pte. Ltd. (Singapore)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Labotect GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Microptic SL (Spain)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Cook Medical LLC (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Xilloc Medical B.V. (Netherlands)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • K-Systems Corp. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • IVFtech ApS (Denmark)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Genea Biomedx (Australia)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments